Carter U. Brzezinski, Sergio A. Solis, Hannah S. Slocumb, John Bacsa, Kyle F. Biegasiewicz
{"title":"Development of a Screening Workflow for the Halogenation of Nitrogen Heterocycles with Vanadium-Dependent Haloperoxidases","authors":"Carter U. Brzezinski, Sergio A. Solis, Hannah S. Slocumb, John Bacsa, Kyle F. Biegasiewicz","doi":"10.1021/acsbiomedchemau.6c00157","DOIUrl":null,"url":null,"abstract":"<p>The halogenation\r\nof nitrogen heterocycles is a privileged transformation\r\nfor accessing important synthetic intermediates and biologically active\r\ntargets in medicinal chemistry. Despite the importance of N-heterocycle\r\nhalogenation, current methods rely on reagents or catalysts that are\r\nlargely unselective and produce a significant number of waste products.\r\nWith an emerging interest in using halogenating enzymes to address\r\nthese challenges, the vanadium-dependent haloperoxidase class of enzymes\r\nhas emerged as a powerful platform for halogenation reactions under\r\na uniquely broad set of reaction conditions. Herein, we report the\r\ndevelopment of a screening workflow for the halogenation of heterocycles\r\nwith chloroperoxidase from <em>Curvularia inaequalis</em> (<em>Ci</em>VCPO). Using a high-throughput screening strategy,\r\nrepresentative model heterocycles are screened for direct chlorination\r\nand bromination reactions, and the optimized conditions are translated\r\nto an extended substrate scope in moderate to high yields. The volume\r\nof high-throughput data obtained allowed for the development of a\r\npredictive model for the substrate halogenation conditions. This screening\r\nplatform is applied to established industrial intermediates and to\r\nthe discovery of previously undiscovered enzymatic nitrogen-chlorine\r\nbond formation and decarboxylative halogenation reactions.</p>","PeriodicalId":29802,"journal":{"name":"ACS Bio & Med Chem Au","volume":"6 5","pages":"733–743"},"PeriodicalIF":3.5000,"publicationDate":"2026-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Bio & Med Chem Au","FirstCategoryId":"1085","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acsbiomedchemau.6c00157","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/10/12 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
The halogenation
of nitrogen heterocycles is a privileged transformation
for accessing important synthetic intermediates and biologically active
targets in medicinal chemistry. Despite the importance of N-heterocycle
halogenation, current methods rely on reagents or catalysts that are
largely unselective and produce a significant number of waste products.
With an emerging interest in using halogenating enzymes to address
these challenges, the vanadium-dependent haloperoxidase class of enzymes
has emerged as a powerful platform for halogenation reactions under
a uniquely broad set of reaction conditions. Herein, we report the
development of a screening workflow for the halogenation of heterocycles
with chloroperoxidase from Curvularia inaequalis (CiVCPO). Using a high-throughput screening strategy,
representative model heterocycles are screened for direct chlorination
and bromination reactions, and the optimized conditions are translated
to an extended substrate scope in moderate to high yields. The volume
of high-throughput data obtained allowed for the development of a
predictive model for the substrate halogenation conditions. This screening
platform is applied to established industrial intermediates and to
the discovery of previously undiscovered enzymatic nitrogen-chlorine
bond formation and decarboxylative halogenation reactions.
期刊介绍:
ACS Bio & Med Chem Au is a broad scope open access journal which publishes short letters comprehensive articles reviews and perspectives in all aspects of biological and medicinal chemistry. Studies providing fundamental insights or describing novel syntheses as well as clinical or other applications-based work are welcomed.This broad scope includes experimental and theoretical studies on the chemical physical mechanistic and/or structural basis of biological or cell function in all domains of life. It encompasses the fields of chemical biology synthetic biology disease biology cell biology agriculture and food natural products research nucleic acid biology neuroscience structural biology and biophysics.The journal publishes studies that pertain to a broad range of medicinal chemistry including compound design and optimization biological evaluation molecular mechanistic understanding of drug delivery and drug delivery systems imaging agents and pharmacology and translational science of both small and large bioactive molecules. Novel computational cheminformatics and structural studies for the identification (or structure-activity relationship analysis) of bioactive molecules ligands and their targets are also welcome. The journal will consider computational studies applying established computational methods but only in combination with novel and original experimental data (e.g. in cases where new compounds have been designed and tested).Also included in the scope of the journal are articles relating to infectious diseases research on pathogens host-pathogen interactions therapeutics diagnostics vaccines drug-delivery systems and other biomedical technology development pertaining to infectious diseases.